GeneDx Historical Income Statement

WGSWW Stock

0.15 0.02 11.76%

Historical analysis of GeneDx Holdings income statement accounts such as Net Interest Income of 1.2 M, Interest Income of 3.1 M, Depreciation And Amortization of 31.3 M or Interest Expense of 2.6 M can show how well GeneDx Holdings Corp performed in making a profits. Evaluating GeneDx Holdings income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of GeneDx Holdings's future profits or losses.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining GeneDx Holdings Corp latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether GeneDx Holdings Corp is a good buy for the upcoming year.

Net Income Gross Profit

Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in GeneDx Holdings Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing.

About GeneDx Income Statement Analysis

GeneDx Holdings Corp Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to GeneDx Holdings shareholders. The income statement also shows GeneDx investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

GeneDx Holdings Income Statement Chart

At this time, GeneDx Holdings' Total Operating Expenses is fairly stable compared to the past year.

Depreciation And Amortization Selling General Administrative Selling And Marketing Expenses Total Revenue Other Operating Expenses

Depreciation And Amortization

The systematic reduction in the recorded value of an intangible asset. This includes the allocation of the cost of tangible assets to periods in which the assets are used, representing the expense related to the wear and tear, deterioration, or obsolescence of physical assets and intangible assets over their useful lives.

Total Revenue

Total revenue comprises all receipts GeneDx Holdings Corp generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of GeneDx Holdings Corp. It is also known as GeneDx Holdings overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Most accounts from GeneDx Holdings' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into GeneDx Holdings Corp current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in GeneDx Holdings Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing.

At this time, GeneDx Holdings' Total Operating Expenses is fairly stable compared to the past year.

	2021	2022	2023	2024 (projected)
Depreciation And Amortization	23.4M	63.0M	33.7M	31.3M
Interest Income	79K	2.5M	2.9M	3.1M

Depreciation And Amortization Interest Income

GeneDx Holdings income statement Correlations

	Net Interest Income	Interest Income	Depreciation And Amortization	Interest Expense	Selling General Administrative	Selling And Marketing Expenses	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Net Income From Continuing Ops	Ebit	Research Development	Ebitda	Cost Of Revenue	Total Operating Expenses	Reconciled Depreciation	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense
Net Interest Income		0.59	-0.12	-0.29	-0.45	-0.47	0.05	0.76	-0.53	0.57	0.44	0.47	-0.61	0.52	-0.52	-0.53	-0.1	0.42	-0.78	0.44	-0.18
Interest Income	0.59		0.7	0.56	0.42	0.39	0.65	-0.07	0.34	-0.28	-0.43	-0.41	0.24	-0.36	0.35	0.34	0.71	-0.44	-0.3	-0.43	-0.57
Depreciation And Amortization	-0.12	0.7		0.84	0.86	0.89	0.84	-0.73	0.85	-0.88	-0.93	-0.92	0.73	-0.89	0.86	0.84	1.0	-0.94	0.35	-0.93	-0.72
Interest Expense	-0.29	0.56	0.84		0.92	0.81	0.56	-0.77	0.85	-0.79	-0.83	-0.86	0.86	-0.85	0.82	0.86	0.85	-0.81	0.41	-0.83	-0.28
Selling General Administrative	-0.45	0.42	0.86	0.92		0.96	0.73	-0.88	0.98	-0.91	-0.89	-0.91	0.97	-0.91	0.96	0.99	0.86	-0.87	0.66	-0.89	-0.3
Selling And Marketing Expenses	-0.47	0.39	0.89	0.81	0.96		0.82	-0.89	0.99	-0.96	-0.93	-0.94	0.93	-0.93	0.99	0.98	0.88	-0.93	0.68	-0.93	-0.46
Total Revenue	0.05	0.65	0.84	0.56	0.73	0.82		-0.48	0.74	-0.7	-0.69	-0.67	0.61	-0.63	0.76	0.74	0.83	-0.7	0.41	-0.69	-0.59
Gross Profit	0.76	-0.07	-0.73	-0.77	-0.88	-0.89	-0.48		-0.92	0.95	0.91	0.93	-0.91	0.95	-0.92	-0.91	-0.72	0.9	-0.72	0.91	0.33
Other Operating Expenses	-0.53	0.34	0.85	0.85	0.98	0.99	0.74	-0.92		-0.95	-0.92	-0.93	0.97	-0.93	0.99	1.0	0.84	-0.9	0.69	-0.91	-0.35
Operating Income	0.57	-0.28	-0.88	-0.79	-0.91	-0.96	-0.7	0.95	-0.95		0.97	0.97	-0.88	0.97	-0.96	-0.94	-0.87	0.97	-0.68	0.97	0.53
Net Income From Continuing Ops	0.44	-0.43	-0.93	-0.83	-0.89	-0.93	-0.69	0.91	-0.92	0.97		1.0	-0.83	0.99	-0.94	-0.9	-0.92	1.0	-0.49	1.0	0.64
Ebit	0.47	-0.41	-0.92	-0.86	-0.91	-0.94	-0.67	0.93	-0.93	0.97	1.0		-0.87	1.0	-0.95	-0.92	-0.91	0.99	-0.51	1.0	0.58
Research Development	-0.61	0.24	0.73	0.86	0.97	0.93	0.61	-0.91	0.97	-0.88	-0.83	-0.87		-0.88	0.95	0.98	0.73	-0.81	0.72	-0.83	-0.14
Ebitda	0.52	-0.36	-0.89	-0.85	-0.91	-0.93	-0.63	0.95	-0.93	0.97	0.99	1.0	-0.88		-0.95	-0.92	-0.88	0.99	-0.53	0.99	0.55
Cost Of Revenue	-0.52	0.35	0.86	0.82	0.96	0.99	0.76	-0.92	0.99	-0.96	-0.94	-0.95	0.95	-0.95		0.99	0.85	-0.93	0.65	-0.94	-0.42
Total Operating Expenses	-0.53	0.34	0.84	0.86	0.99	0.98	0.74	-0.91	1.0	-0.94	-0.9	-0.92	0.98	-0.92	0.99		0.83	-0.89	0.71	-0.9	-0.32
Reconciled Depreciation	-0.1	0.71	1.0	0.85	0.86	0.88	0.83	-0.72	0.84	-0.87	-0.92	-0.91	0.73	-0.88	0.85	0.83		-0.92	0.35	-0.92	-0.71
Income Before Tax	0.42	-0.44	-0.94	-0.81	-0.87	-0.93	-0.7	0.9	-0.9	0.97	1.0	0.99	-0.81	0.99	-0.93	-0.89	-0.92		-0.48	1.0	0.67
Total Other Income Expense Net	-0.78	-0.3	0.35	0.41	0.66	0.68	0.41	-0.72	0.69	-0.68	-0.49	-0.51	0.72	-0.53	0.65	0.71	0.35	-0.48		-0.49	0.1
Net Income	0.44	-0.43	-0.93	-0.83	-0.89	-0.93	-0.69	0.91	-0.91	0.97	1.0	1.0	-0.83	0.99	-0.94	-0.9	-0.92	1.0	-0.49		0.64
Income Tax Expense	-0.18	-0.57	-0.72	-0.28	-0.3	-0.46	-0.59	0.33	-0.35	0.53	0.64	0.58	-0.14	0.55	-0.42	-0.32	-0.71	0.67	0.1	0.64

Click cells to compare fundamentals

GeneDx Holdings Account Relationship Matchups

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

Additional Tools for GeneDx Stock Analysis

When running GeneDx Holdings' price analysis, check to measure GeneDx Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GeneDx Holdings is operating at the current time. Most of GeneDx Holdings' value examination focuses on studying past and present price action to predict the probability of GeneDx Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GeneDx Holdings' price. Additionally, you may evaluate how the addition of GeneDx Holdings to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

GeneDx Historical Income Statement

About GeneDx Income Statement Analysis

GeneDx Holdings Income Statement Chart

Depreciation And Amortization

Total Revenue

Other Operating Expenses

GeneDx Holdings income statement Correlations

GeneDx Holdings Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Also Currently Popular

Additional Tools for GeneDx Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Tax Provision	Net Interest Income
Interest Income	Depreciation And Amortization
Interest Expense	Selling General Administrative
Selling And Marketing Expenses	Total Revenue
Gross Profit	Other Operating Expenses
Operating Income	Net Income From Continuing Ops
Ebit	Research Development
Ebitda	Cost Of Revenue
Total Operating Expenses	Reconciled Depreciation
Income Before Tax	Total Other Income Expense Net
Net Income	Income Tax Expense

Reconciled Depreciation	+ 1.0	Depreciation And Amortization
Total Operating Expenses	+ 1.0	Other Operating Expenses
Ebit	+ 1.0	Net Income From Continuing Ops
Income Before Tax	+ 1.0	Net Income From Continuing Ops
Net Income	+ 1.0	Net Income From Continuing Ops
Ebitda	+ 1.0	Ebit

Cost Of Revenue	- 0.96	Operating Income
Operating Income	- 0.96	Selling And Marketing Expenses
Cost Of Revenue	- 0.95	Ebitda
Cost Of Revenue	- 0.95	Ebit
Operating Income	- 0.95	Other Operating Expenses
Net Income	- 0.94	Cost Of Revenue